Overview
PaceMate provides remote cardiac monitoring through a cloud-based platform that healthcare providers use to collect, monitor, and analyze real-time heart data from patients. The system supports virtual care by integrating telemedicine features such as videoconferencing and continuous data streams, enabling clinicians to assess heart health without in-person visits. The product works by gathering data from patients’ monitoring devices, sending it to the cloud where it is analyzed, and delivering actionable insights to clinicians for timely decisions. PaceMate differentiates itself by combining real-time analytics with seamless telemedicine integration and by forming partnerships with healthcare organizations on a subscription model, rather than relying on standalone devices. Its goal is to improve patient outcomes, increase the efficiency of cardiac care, and reduce infection risk by enabling safe, remote monitoring and care at scale.
Work here?Claim your company
Simplify's take
What believers are saying
- PaceMate manages 2.3 million patients across health systems, proving national operating scale.
- September 2025 AI leadership and April 2026 CMO hires sharpen product credibility and workflow automation.
- The August 2025 Medtronic Paceart acquisition expands data access and accelerates customer conversion.
What critics are saying
- PaceMate has raised only $8 million, limiting enterprise sales, integrations, and AI burn.
- Medtronic and Philips still control downstream cardiac workflow relationships and buyer trust.
- If hospitals delay cloud migration, PaceMateLIVE stalls and PaceMate becomes a niche services vendor.
What makes PaceMate unique
- PaceMate controls Paceart data migration and Medtronic Paceart Optima workflows.
- PaceMateLIVE unifies ordering, monitoring, reporting, and billing in one cloud platform.
- JR Finkelmeier brought Philips ambulatory monitoring scale into PaceMate's commercial strategy.
Help us improve and share your feedback! Did you find this helpful?